Prosecution Insights
Last updated: October 25, 2026

Wc&F Ip

Technology area: Biotechnology & Pharmaceuticals

158 pending office actions • 104 clients • 145 examiners • 84 art units • 0 of 158 (0%) have an AI response strategy ready • 225 patents granted in the last 365 days

Analysis

WC&F IP works in Biotechnology & Pharmaceuticals and has 7,299 career applications. Its resolved allowance rate is 78.17%, providing an outcome measure across a substantial application history.

The profile shows 157 pending office actions and an average of 3.24 office actions per allowance. The pending docket represents active workload, while the response average indicates that allowed matters commonly required several office-action cycles.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=7299 apps, methodology: how we score firms)

78.2%
Allowance Rate
n=7299
+0.53σ
Allowance Rate (norm)
n=7299
3.2
OAs to Allowance
n=4265
-0.25σ
OAs to Allow (norm)
n=4265
983 days
Time to Allowance
n=4265
+16.7pp
Interview Lift
n=7299
23.5%
RCE Rate
n=7299
2.0%
Appeal Rate
n=7299

Rejection Performance (% of received rejections ultimately overcome)

70.6%
§101 Overcome
n=625
72.0%
§102 Overcome
n=1776
72.9%
§103 Overcome
n=2833
75.3%
§112 Overcome
n=2496

Specialization & Scale

A61K, A61P, G01N
Top CPC Subclasses
26%
Top-3 CPC Share
n=7299
0
Practitioners
n=7299
—
Apps / Practitioner
n=7299 (min 20)

Portfolio Summary

158
Total Pending OAs
104
Non-Final OAs
49
Final Rejections
5
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 47 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

22
Overdue
0
Due this week
13
Due this month
6
Due in next 60 days
6
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 47 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (22)Due ≤ 30 days (13)Due ≤ 60 days (6)Due later (6)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

76
Hard (48%)
55
Medium (35%)
27
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other16 (10%)
§103 only40 (25%)
§102 only4 (3%)
§112 only24 (15%)
Double-patenting only3 (2%)
Double-patenting + other11 (7%)
Multi-statute (no §101)60 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

109
Life Sciences
69% of docket
2
Information Tech
1% of docket
7
Communications
4% of docket
5
Semiconductors
3% of docket
29
Mechanical / Eng
18% of docket
6
Business / Other
4% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

1,580 h
Manual time on pending OAs
316 h
Time saved (low, 20%)
553 h
Time saved (mid, 35%)
13.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DABKOWSKI, ERINNE R 3 55.8% +68.7%
CHATTIN, AMY MARIE 2 72.2% +45.7%
WILLSE, DAVID H 2 67.3% +14.0%
GONZALEZ, LUISALBERTO 2 59.7% +46.3%
LU, CHENG 2 53.8% +64.6%
ALAM, DANYAL HASSAN 2 66.7% +0.0%
QIAN, CELINE X 2 47.5% +17.2%
BEANE, RANDALL L 2 32.9% +36.2%
YU, DELPHINUS DOU YI 2 33.3% +0.0%
ARMATO JR, DENNIS IGNATIUS 2 42.9% +80.0%

Hard Cases (76)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18702042 DATA PROCESSING METHOD, DATA PROCESSING DEVICE, AND COMPUTER PROGRAM HAIDER, FAWAAD 131d overdue
17760024 METHODS OF TREATMENT OF CANCER DISEASE BY TARGETING AN EPIGENETIC FACTOR SABILA, MERCY HELLEN 126d overdue
18031251 TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES HIBBERT, CATHERINE S 105d overdue
18247945 GDF3 AS BIOMARKER AND BIOTARGET IN POST-ISCHEMIC CARDIAC REMODELING LUSI, ELLIS FOLLETT 103d overdue
18280151 A STRUCTURAL REPAIR PATCH SYSTEM FOR REPAIRING A DAMAGED SURFACE OF A PRODUCT KOCH, GEORGE R 97d overdue
18006414 GRANULATED EXPLOSIVE BASED ON A WATER-IN-OIL EMULSION, AND PRODUCTION AND USE THEREOF FELTON, AILEEN BAKER 73d overdue
17606618 INTRACORPOREAL GUIDE COMPONENT BACHMAN, LINDSEY MICHELE 51d overdue
18009006 Treatment of Genetic Dilated Cardiomyopathies CONNORS, ALEXANDRA F 30d overdue

Interview Candidates (17)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18275331 BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES ARMATO JR, DENNIS IGNATIUS 30d overdue
17573913 POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA DABKOWSKI, ERINNE R 10d overdue
18553082 PROSTHESIS SOCKET SYSTEM AND METHOD FOR PRODUCING SAME WILLSE, DAVID H 14d
18263014 METHODS OF ASSESSING THE RISK OF DEVELOPING PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN PATIENTS TREATED WITH VLA-4 ANTAGONISTS LU, CHENG 15d
18575454 NEW METHOD TO TREAT ACIDOSIS RELATED DISEASES WITH ACETOACETATE GONZALEZ, LUISALBERTO 27d
18246270 BIFUNCTIONAL LENTIVIRAL VECTORS ALLOWING THE BS-GLOBIN SILENCING AND EXPRESSION OF AN ANTI-SICKLING HBB AND USES THEREOF FOR GENE THERAPY OF SICKLE CELL DISEASE QIAN, CELINE X 29d
18495355 POLYPEPTIDE FOR USE IN THE PROTECTION OF OXYGEN SENSITIVE GRAM-POSITIVE BACTERIA DABKOWSKI, ERINNE R 43d
19196172 ANTIBODIES HAVING SPECIFICITY FOR CD38 AND USES THEREOF CHATTIN, AMY MARIE —

Client Portfolio (104 clients)

Client (Assignee)Pending OAs
Ottobock 13
Université Paris Cité 8
AP-HP 6
Centre National de la Recherche Scientifique 5
VIRGINIA COMMONWEALTH UNIVERSITY 5
Université Côte d'Azur 4
Audio-Technica 3
Université de Montpellier 3
Université de Lyon 3
Sorbonne Université 3
Université Toulouse Iii - Paul Sabatier 2
ECOLE SUPÉRIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS 2
Karl Heesemann Maschinenfabrik GmbH & Co. Kg 2
Institut Pasteur 2
CINOGY GMBH 2
CNRS 2
THE HEALTHY AGING COMPANY 2
Forschungszentrum Borstel 2
INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE 2
Université d'Évry 2
Fondation Imagine 2
Neurocia SAS 1
Seenel Imaging 1
George Mason University 1
Centre Hospitalier Universitaire De Toulouse 1
Gottfried Wilhelm Leibniz Universität Hannover 1
Hangzhou Dianzi University 1
Université Paris Sciences Et Lettres 1
Nantes Université 1
Information Technology Research Center, Beijing Academy Of Agriculture And Forestry Sciences 1
Université Paris-Saclay 1
Solar Materials GmbH 1
Ecole Nationale Vétérinaire De Toulouse 1
Heatex Sensing Technology (Huzhou) Co., Ltd. 1
Faircraft 1
Institut National de La Sante Et de La Recherche Medicale (inserm) 1
Advanced Energy Materials 1
Fondation Asile Des Aveugles 1
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER 1
NIKKISO CO., LTD. 1
SWISS KRONO TEC AG 1
Children'S Hospital Of Philadelphia (Chop) 1
Greenpharma SAS 1
Institut de Myologie 1
WASHINGTON STATE UNIVERSITY 1
Medykal AG 1
Institut Bergonié 1
Association Francaise Contre Les Myopathies (A.F.M.) 1
REMEDEE LABS 1
Lexat 1

View all 104 →

Top Art Units

Art UnitApps
37748
16548
16426
16435
16354
16754
16123
16383
16263
16233

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19196172 ANTIBODIES HAVING SPECIFICITY FOR CD38 AND USES THEREOF UNIVERSITE DE PARIS CHATTIN, AMY MARIE 1643 §112Other Final Rejection — Pending May 01, 2025
19122030 EARPHONE DEVICE Audio-Technica Corporation EASON, MATTHEW A 2624 §102§103 Non-Final OA — Pending Apr 17, 2025
19093976 MICROPHONE APPARATUS Audio-Technica Corporation SNIEZEK, ANDREW L 2693 §103 Non-Final OA — Pending Mar 28, 2025
19110270 METHODS OF DIAGNOSING ACUTE CIRCULATORY FAILURE Université Toulouse Iii - Paul Sabatier KAUR, GURPREET 1795 §102§103§112 Non-Final OA — Pending Mar 10, 2025
19055896 BODY TISSUE RADIOFREQUENCY APPLICATORS, HEAD DEVICE AND USES THEREOF Neurocia SAS LEE, BRYAN MCALLISTER 3796 §103 Non-Final OA — Pending Feb 18, 2025
18997123 INTRAPARTUM MEASUREMENT PROBE AND DEVICE AND DELIVERY MONITORING SYSTEM Seenel Imaging FARDANESH, MARJAN 3792 §102§112 Non-Final OA — Pending Jan 20, 2025
19028800 FIBER ALIGNMENT IN STEREOLITHOGRAPHY (SLA) 3D PRINTING OF COMPOSITE POLYMERS George Mason University SMITH JR., JIMMY R §102 Non-Final OA — Pending Jan 17, 2025
18995966 COMBINATION OF DASATINIB AND LOVASTATIN FOR USE IN METHODS FOR THE TREATMENT OF CARDIAC FIBROSIS Centre Hospitalier Universitaire De Toulouse ROBINSON, MIKHAIL O'DONNEL §103 Non-Final OA — Pending Jan 17, 2025
18992428 ION MOBILITY SPECTROMETER, AND METHOD FOR ANALYSING SUBSTANCES Gottfried Wilhelm Leibniz Universität Hannover MAINI, RAHUL 2858 §102§103§112 Non-Final OA — Pending Jan 08, 2025
19013824 METHOD AND SYSTEM FOR ATTRIBUTE COMMUNITY SEARCH BASED ON RELATION TREE Hangzhou Dianzi University NGUYEN, PHONG H 2156 §101§112 Non-Final OA — Pending Jan 08, 2025
18881505 EXTRACELLULAR VESICLES FUNCTIONALIZED WITH AN ERV SYNCITIN AND USES THEREOF FOR CARGO DELIVERY Université Paris Sciences Et Lettres RONEY, CELESTE A 1612 §103DP Non-Final OA — Pending Jan 06, 2025
18878699 METHOD FOR RECOGNIZING BIFURCATIONS IN A VASCULAR TREE, ASSOCIATED METHODS AND DEVICES Nantes Université CASCAIS, JUSTIN PHILIP 2668 §101§103 Non-Final OA — Pending Dec 24, 2024
19000803 METHOD AND APPARATUS FOR CALCULATING PLANT HEIGHT UNIFORMITY OF CROP POPULATION, DEVICE, AND MEDIUM Information Technology Research Center, Beijing Academy Of Agriculture And Forestry Sciences WOLFSON, ETHAN NOAH 2673 §103 Non-Final OA — Pending Dec 24, 2024
18865879 SELF-POSITIONING ACOUSTIC LENS Ecole Supérieure De Physique Et De Chimie Industrielles De La Ville De Paris HOFFA, ANGELA MARIE 3799 §103§112 Final Rejection 29d overdue Pending Nov 14, 2024
18863355 METHOD FOR PROCESSING 3D IMAGING DATA AND ASSISTING WITH PROGNOSIS OF CANCER Universite Paris-Saclay VARNDELL, ROSS E 2668 §103§112 Non-Final OA — Pending Nov 06, 2024
18862795 METHOD FOR PROCESSING A LAYER ELEMENT Solar Materials GmbH DODDS, SCOTT 1746 §103 Final Rejection — Pending Nov 04, 2024
18860855 USE OF SHP2 INHIBITORS FOR INHIBITING SENESCENCE Ecole Nationale Vétérinaire De Toulouse MARTIN, KEVIN STEPHEN §102§112Other Non-Final OA — Pending Oct 28, 2024
18860109 PROSTHESIS COVER AND METHOD FOR PRODUCING A PROSTHESIS COVER Otto Bock Healthcare Products GmbH WILLSE, DAVID H 3774 §102§103 Non-Final OA — Pending Oct 25, 2024
18925210 PHOTODETECTOR BASED ON TRANSVERSE DEMBER EFFECT AND PREPARATION METHOD THEREOF Heatex Sensing Technology (Huzhou) Co., Ltd. SECK, AHMED F 2834 §103§112 Non-Final OA — Pending Oct 24, 2024
18857943 A METHOD FOR DETERMINING THE VELOCITY OF A NATURAL SHEAR WAVE PROPAGATING IN A MEDIUM Ecole Supérieure De Physique Et De Chimie Industrielles De La Ville De Paris YOUNG, MONICA S 2855 §103§112 Non-Final OA — Pending Oct 18, 2024
18857952 METHOD FOR PRODUCING LEATHER USING CELL CULTURE ON HONEYCOMB MACROPOROUS POLYMERIC SCAFFOLD Faircraft VIJAYARAGHAVAN, JAGAMYA NMN 1633 §103§112DP Non-Final OA — Pending Oct 18, 2024
18855427 LIPOPEPTIDE COMPOUND AND TREATMENT OF PAIN DISORDER UNIVERSITE DE MONTPELLIER O DELL, DAVID K 1692 §101§102§103§112 Non-Final OA — Pending Oct 09, 2024
18853607 METHOD AND APPARATUS FOR ULTRASONIC EVALUATION OF AN ISOLATED ORGAN UNIVERSITE CLAUDE BERNARD - LYON 1 ARMSTRONG, JONATHAN D 3645 §103 Final Rejection 76d Pending Oct 02, 2024
18850339 SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS INSERM BURKETT, DANIEL JOHN §112 Non-Final OA — Pending Sep 24, 2024
18843732 METHOD FOR DETERMINING A PARAMETER OF THE RESPONSE OF AN AUDITORY NERVE OF A SUBJECT AND ASSOCIATED METHODS AND DEVICES UNIVERSITE DE MONTPELLIER LIU, CHU CHUAN 3791 §101§102§112 Non-Final OA — Pending Sep 04, 2024
18837772 PROSTHETIC GLOVE AND METHOD FOR PRODUCING SAME Otto Bock Healthcare Products GmbH WEIS, RAQUEL M. 3732 §102§103 Non-Final OA — Pending Aug 12, 2024
18800041 MODULAR PRODUCTION OF AMMONIA Advanced Energy Materials, LLC IQBAL, SYED TAHA 1736 §102§103 Non-Final OA — Pending Aug 10, 2024
18799279 ELECTROACOUSTIC TRANSDUCER Audio-Technica Corporation RINEHART, SEAN MICHAEL 2694 §103 Final Rejection 23d overdue Pending Aug 09, 2024
18786774 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHOROIDAL NEOVASCULARISATION Fondation Asile Des Aveugles RODRIGUEZ, RAYNA B 1628 §102§103 Non-Final OA — Pending Jul 29, 2024
18782422 DEVICE FOR JOINT EXTRACTION OF A METAL CATION AND A TARGET MOLECULE Centre National De La Recherche Scientifique - Cnrs - MENON, KRISHNAN S 1771 §102§103§112 Non-Final OA — Pending Jul 24, 2024
18832633 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING TEAR FILM COMPOSITION TO TREAT CORNEAL DEFECTS Centre Hospitalier Universitaire De Montpellier JACKSON III, WALTER 1638 §102§103 Non-Final OA — Pending Jul 24, 2024
18782375 MOTOR BEARING WEAR MONITORING DEVICE, METHOD FOR ADJUSTING MOTOR BEARING WEAR MONITORING DEVICE AND PROGRAM Nikkiso Co., Ltd. SPLIT, JAMES GERALD 2858 §112 Non-Final OA — Pending Jul 24, 2024
18730927 COMPOUND FOR USE IN PREVENTING AND/OR TREATING AN INFECTION CAUSED BY SARS-COV-2 UNIVERSITE PARIS CITE JAUHARI, SACHI 1654 §103Other Non-Final OA — Pending Jul 22, 2024
18772744 CONSTRUCTS COMPRISING NEURONAL VIABILITY FACTORS AND USES THEREOF Sorbonne Universite AMICK, THOMAS RUSSE 1638 DP Non-Final OA — Pending Jul 15, 2024
18728647 METHOD FOR PRODUCING DECORATIVE PAPER Swiss Krono Tec AG MCMILLION, TRACEY M 2853 §103 Final Rejection 39d Pending Jul 12, 2024
18727826 NALTREXAMINE DERIVATIVES BEARING 5-MEMBER HETEROCYCLIC RING SYSTEMS AND OPIOID RECEPTOR MODULATORS VIRGINIA COMMONWEALTH UNIVERSITY STOCKTON, LAURA LYNNE 1626 §102§112Other Non-Final OA — Pending Jul 10, 2024
18767363 BENZALDEHYDE COMPOUNDS WITH DIRECT POLYMER DESTABILIZING EFFECTS TO TREAT SICKLE CELL DISEASE Children'S Hospital Of Philadelphia (Chop) ANDERSON, REBECCA L 1626 DP Non-Final OA — Pending Jul 09, 2024
18725323 GERALEXIN AND USES THEREOF FOR THE TREATMENT OF RETINAL DEGENERATIVE DISEASES Greenpharma SAS VISHNYAKOVA, ELENA VLADIMIROVNA 1691 §101§112 Non-Final OA — Pending Jun 28, 2024
18725322 METHODS OF INDUCING CELL DEATH OF A POPULATION OF SOLID TUMOR CELLS UNIVERSITE PARIS CITE CONSTANTINE, CHARLES Z 1657 §112 Non-Final OA — Pending Jun 28, 2024
18748524 ADJUSTMENT VALVE Otto Bock Healthcare Products GmbH MANNAN, MIKAIL A 3774 §102§103Other Non-Final OA — Pending Jun 20, 2024
18721781 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS Centre National De La Recherche Scientifique CHICKS, ASHLI ARIANA 1626 §112 Final Rejection — Pending Jun 19, 2024
18720245 Method for Controlling a Prosthetic and/or Orthotic System and such a System Otto Bock Healthcare Products GmbH STRANSKY, KATRINA MARIE 3700 §102§103§112 Non-Final OA — Pending Jun 14, 2024
18742261 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RETINAL CAPILLARY NON-PERFUSION Sorbonne Université LEE, ANDREW P 1691 §112 Non-Final OA — Pending Jun 13, 2024
18718997 ORTHOPAEDIC DEVICE AND METHOD FOR PRODUCING SAME Otto Bock Healthcare Products GmbH PATEL, NITIN 2628 §102 Non-Final OA — Pending Jun 12, 2024
18718508 ACTUATOR AND ORTHOPEDIC TECHNICAL JOINT DEVICE, AND METHOD FOR CONTROLLING SAME Otto Bock Healthcare Products GmbH COCHRAN, KARI LEE 3774 §102§103 Non-Final OA — Pending Jun 11, 2024
18718519 METHODS AND COMPOSITIONS FOR TREATING MELANOMA UNIVERSITE COTE D'AZUR GONZALEZ, LUISALBERTO 1624 §102§103 Non-Final OA — Pending Jun 11, 2024
18718498 PROSTHETIC SOCKET Ottobock SE & Co. Kgaa GHERBI, SUZETTE JAIME J 3774 §102§103 Non-Final OA — Pending Jun 11, 2024
18717719 USE OF CATECHIN FOR THE TREATMENT OF FGFR-RELATED BONE REPAIR AND BONE FORMATION IMPAIRMENT Assistance Publique-Hôpitaux De Paris (Aphp) MCMILLIAN, KARA RENITA 1623 §103§112Other Non-Final OA — Pending Jun 07, 2024
18717710 COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICITS WITH A CATECHIN Assistance Publique-Hôpitaux De Paris (Aphp) WELLS, LAUREN QUINLAN 1622 §103DP Final Rejection — Pending Jun 07, 2024
18735636 Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism Association Institut De Myologie WESTON, ALYSSA G 1633 §102§103§112DPOther Non-Final OA — Pending Jun 06, 2024

View all 158 →

Managing Wc&F Ip's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Wc&F Ip's patent allowance rate?

78.2% of resolved applications prosecuted by Wc&F Ip were allowed, across 7,299 applications in USPTO records.

How many office actions does Wc&F Ip average before allowance?

3.24 office actions per allowed application on average.

How many pending office actions does Wc&F Ip have?

158 pending office actions as of October 2026, for 104 clients, before 145 examiners in 84 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month